OrganOx Ltd. develops advanced medical devices for preserving and assessing donor livers using normothermic machine perfusion technology. Based in Oxford, United Kingdom, the company addresses critical challenges in organ transplantation by maintaining donor organs at body temperature with continuous blood flow, enabling better preservation and real-time assessment of organ viability. This innovative approach represents a significant advancement over traditional cold storage methods, potentially increasing the number of viable organs available for transplantation and improving patient outcomes. OrganOx continues to focus on expanding its organ preservation platform and advancing clinical applications in transplant medicine.